Matches in SemOpenAlex for { <https://semopenalex.org/work/W2912141088> ?p ?o ?g. }
- W2912141088 endingPage "e0211153" @default.
- W2912141088 startingPage "e0211153" @default.
- W2912141088 abstract "The tumor suppressor p16Ink4a, encoded by the INK4a gene, is an inhibitor of cyclin D-dependent kinases 4 and 6, CDK4 and CDK6. This inhibition prevents the phosphorylation of the retinoblastoma protein (pRb), resulting in cellular senescence through inhibition of E2F-mediated transcription of S phase genes required for cell proliferation. The p16Ink4a plays an important role in tumor suppression, whereby its deletion, mutation, or epigenetic silencing is a frequently observed genetic alteration in prostate cancer. To assess its roles and related molecular mechanisms in prostate cancer initiation and progression, we generated a mouse model with conditional deletion of p16Ink4a in prostatic luminal epithelium. The mice underwent oncogenic transformation and developed prostatic intraepithelial neoplasia (PIN) from eight months of age, but failed to develop prostatic tumors. Given the prevalence of aberrant androgen signaling pathways in prostate cancer initiation and progression, we then generated R26hARL/wt:p16L/L: PB-Cre4 compound mice, in which conditional expression of the human AR transgene and deletion of p16Ink4a co-occur in prostatic luminal epithelial cells. While R26hARL/wt:PB-Cre4 mice showed no visible pathological changes, R26hARL/wt:p16L/L: PB-Cre4 compound mice displayed an early onset of high-grade PIN (HGPIN), prostatic carcinoma, and metastatic lesions. Strikingly, we observed tumors resembling human sarcomatoid carcinoma with intermixed focal regions of signet ring cell carcinoma (SRCC) in the prostates of the compound mice. Further characterization of these tumors showed they were of luminal epithelial cell origin, and featured characteristics of epithelial to mesenchymal transition (EMT) with enhanced proliferative and invasive capabilities. Our results not only implicate a biological role for AR expression and p16Ink4a deletion in the pathogenesis of prostatic SRCC, but also provide a new and unique genetically engineered mouse (GEM) model for investigating the molecular mechanisms for SRCC development." @default.
- W2912141088 created "2019-02-21" @default.
- W2912141088 creator A5000564724 @default.
- W2912141088 creator A5000607183 @default.
- W2912141088 creator A5002353139 @default.
- W2912141088 creator A5012809119 @default.
- W2912141088 creator A5024624464 @default.
- W2912141088 creator A5029336998 @default.
- W2912141088 creator A5038068584 @default.
- W2912141088 creator A5040455330 @default.
- W2912141088 creator A5041558880 @default.
- W2912141088 creator A5043155869 @default.
- W2912141088 creator A5044917800 @default.
- W2912141088 creator A5057272279 @default.
- W2912141088 creator A5076273517 @default.
- W2912141088 creator A5081792894 @default.
- W2912141088 creator A5089961911 @default.
- W2912141088 date "2019-01-24" @default.
- W2912141088 modified "2023-09-26" @default.
- W2912141088 title "Deletion of the p16INK4a tumor suppressor and expression of the androgen receptor induce sarcomatoid carcinomas with signet ring cells in the mouse prostate" @default.
- W2912141088 cites W1578291413 @default.
- W2912141088 cites W1599189014 @default.
- W2912141088 cites W1965283193 @default.
- W2912141088 cites W1977704448 @default.
- W2912141088 cites W1982530242 @default.
- W2912141088 cites W1986763150 @default.
- W2912141088 cites W1991560250 @default.
- W2912141088 cites W1992411393 @default.
- W2912141088 cites W1995142571 @default.
- W2912141088 cites W1999339142 @default.
- W2912141088 cites W2002791165 @default.
- W2912141088 cites W2003955264 @default.
- W2912141088 cites W2010493387 @default.
- W2912141088 cites W2019510283 @default.
- W2912141088 cites W2019517928 @default.
- W2912141088 cites W2023310075 @default.
- W2912141088 cites W2024386994 @default.
- W2912141088 cites W2024850963 @default.
- W2912141088 cites W2028041362 @default.
- W2912141088 cites W2029451113 @default.
- W2912141088 cites W2037009566 @default.
- W2912141088 cites W2038212096 @default.
- W2912141088 cites W2051025382 @default.
- W2912141088 cites W2064117760 @default.
- W2912141088 cites W2076414045 @default.
- W2912141088 cites W2079003861 @default.
- W2912141088 cites W2080185306 @default.
- W2912141088 cites W2080724768 @default.
- W2912141088 cites W2082279608 @default.
- W2912141088 cites W2086629202 @default.
- W2912141088 cites W2095690095 @default.
- W2912141088 cites W2102892939 @default.
- W2912141088 cites W2110716113 @default.
- W2912141088 cites W2125069527 @default.
- W2912141088 cites W2125819870 @default.
- W2912141088 cites W2127425327 @default.
- W2912141088 cites W2137928263 @default.
- W2912141088 cites W2148180201 @default.
- W2912141088 cites W2154676564 @default.
- W2912141088 cites W2157957734 @default.
- W2912141088 cites W2161112598 @default.
- W2912141088 cites W2161743101 @default.
- W2912141088 cites W2162923066 @default.
- W2912141088 cites W2167609397 @default.
- W2912141088 cites W2214074259 @default.
- W2912141088 cites W2563892320 @default.
- W2912141088 cites W2737074681 @default.
- W2912141088 cites W2772130247 @default.
- W2912141088 cites W2772352511 @default.
- W2912141088 cites W2772894471 @default.
- W2912141088 cites W4253929113 @default.
- W2912141088 doi "https://doi.org/10.1371/journal.pone.0211153" @default.
- W2912141088 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/6345450" @default.
- W2912141088 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/30677079" @default.
- W2912141088 hasPublicationYear "2019" @default.
- W2912141088 type Work @default.
- W2912141088 sameAs 2912141088 @default.
- W2912141088 citedByCount "3" @default.
- W2912141088 countsByYear W29121410882019 @default.
- W2912141088 countsByYear W29121410882021 @default.
- W2912141088 countsByYear W29121410882022 @default.
- W2912141088 crossrefType "journal-article" @default.
- W2912141088 hasAuthorship W2912141088A5000564724 @default.
- W2912141088 hasAuthorship W2912141088A5000607183 @default.
- W2912141088 hasAuthorship W2912141088A5002353139 @default.
- W2912141088 hasAuthorship W2912141088A5012809119 @default.
- W2912141088 hasAuthorship W2912141088A5024624464 @default.
- W2912141088 hasAuthorship W2912141088A5029336998 @default.
- W2912141088 hasAuthorship W2912141088A5038068584 @default.
- W2912141088 hasAuthorship W2912141088A5040455330 @default.
- W2912141088 hasAuthorship W2912141088A5041558880 @default.
- W2912141088 hasAuthorship W2912141088A5043155869 @default.
- W2912141088 hasAuthorship W2912141088A5044917800 @default.
- W2912141088 hasAuthorship W2912141088A5057272279 @default.
- W2912141088 hasAuthorship W2912141088A5076273517 @default.
- W2912141088 hasAuthorship W2912141088A5081792894 @default.
- W2912141088 hasAuthorship W2912141088A5089961911 @default.
- W2912141088 hasBestOaLocation W29121410881 @default.